Cargando…

Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis

BACKGROUND: Patients with recurrent retroperitoneal and pelvic region tumors often require multimodal therapies. Intraoperative radiation therapy (IORT) can deliver high-dose radiation to tumor beds, even if first-line external beam radiation therapy (EBRT) was administered. We evaluated local contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Tharcisio Machado, Fogaroli, Ricardo César, Pellizzon, Antonio Cassio Assis, De Castro, Douglas Guedes, Gondim, Guilherme Rocha Melo, Silva, Maria Leticia Gobo, Chen, Michael Jenwei, Ramos, Henderson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245634/
https://www.ncbi.nlm.nih.gov/pubmed/30454036
http://dx.doi.org/10.1186/s13014-018-1168-x
_version_ 1783372279434969088
author Coelho, Tharcisio Machado
Fogaroli, Ricardo César
Pellizzon, Antonio Cassio Assis
De Castro, Douglas Guedes
Gondim, Guilherme Rocha Melo
Silva, Maria Leticia Gobo
Chen, Michael Jenwei
Ramos, Henderson
author_facet Coelho, Tharcisio Machado
Fogaroli, Ricardo César
Pellizzon, Antonio Cassio Assis
De Castro, Douglas Guedes
Gondim, Guilherme Rocha Melo
Silva, Maria Leticia Gobo
Chen, Michael Jenwei
Ramos, Henderson
author_sort Coelho, Tharcisio Machado
collection PubMed
description BACKGROUND: Patients with recurrent retroperitoneal and pelvic region tumors often require multimodal therapies. Intraoperative radiation therapy (IORT) can deliver high-dose radiation to tumor beds, even if first-line external beam radiation therapy (EBRT) was administered. We evaluated local control (LC) and survival in patients receiving IORT for recurrent tumors. METHODS: We retrospectively analyzed 41 patients with isolated pelvic or retroperitoneal recurrences of colorectal, gynecological, or retroperitoneal primary tumors. Following salvage surgery, all patients underwent tumor bed IORT via electron beam or high dose rate brachytherapy. Isolated IORT (median dose: 15 Gy) was administered to patients who had received first-line EBRT; other patients received IORT (median dose 12 Gy) plus EBRT. Local (LF), regional (RF), and distant failures (DF) were evaluated, and the Kaplan–Meier method and log-rank test were used to evaluate and compare overall survival (OS) from the date of IORT. RESULTS: Forty-one patients underwent 44 treatments, including 27 (61.3%) isolated IORT and 17 (38.7%) IORT and EBRT combination regimens. The median follow-up was 8.1 years (range: 4.4–11.7 years), and the 2, 5, and 8 year overall LC rates were 87.9, 64.0, and 49.8%, respectively. Regarding resection status, the respective 2, 5, and 8 year LC rates were 90, 76, and 76% for R0 resection and 75, 25, and 0% for R1 resection (p < 0.001). The 2, 5, and 8 year OS rates were 68, 43, and 26%, respectively. OS was better among patients with LC (p < 0.001). Twenty-four patients (58.5%) experienced a DF, and the 5 year OS rates for the patients with and without DF were 36 and 52%, respectively (p = 0.04). In a multivariate analysis, LF (p = 0,012) and recurrent retroperitoneal sarcoma (p = 0,014) were identified as significant predictors of worse OS. Thirteen patients (31%) developed clinically treatable complications related to IORT. CONCLUSIONS: Many patients achieve long-term OS and LC without significant morbidity after salvage surgery and IORT, especially in case of clear margins.
format Online
Article
Text
id pubmed-6245634
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62456342018-11-26 Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis Coelho, Tharcisio Machado Fogaroli, Ricardo César Pellizzon, Antonio Cassio Assis De Castro, Douglas Guedes Gondim, Guilherme Rocha Melo Silva, Maria Leticia Gobo Chen, Michael Jenwei Ramos, Henderson Radiat Oncol Research BACKGROUND: Patients with recurrent retroperitoneal and pelvic region tumors often require multimodal therapies. Intraoperative radiation therapy (IORT) can deliver high-dose radiation to tumor beds, even if first-line external beam radiation therapy (EBRT) was administered. We evaluated local control (LC) and survival in patients receiving IORT for recurrent tumors. METHODS: We retrospectively analyzed 41 patients with isolated pelvic or retroperitoneal recurrences of colorectal, gynecological, or retroperitoneal primary tumors. Following salvage surgery, all patients underwent tumor bed IORT via electron beam or high dose rate brachytherapy. Isolated IORT (median dose: 15 Gy) was administered to patients who had received first-line EBRT; other patients received IORT (median dose 12 Gy) plus EBRT. Local (LF), regional (RF), and distant failures (DF) were evaluated, and the Kaplan–Meier method and log-rank test were used to evaluate and compare overall survival (OS) from the date of IORT. RESULTS: Forty-one patients underwent 44 treatments, including 27 (61.3%) isolated IORT and 17 (38.7%) IORT and EBRT combination regimens. The median follow-up was 8.1 years (range: 4.4–11.7 years), and the 2, 5, and 8 year overall LC rates were 87.9, 64.0, and 49.8%, respectively. Regarding resection status, the respective 2, 5, and 8 year LC rates were 90, 76, and 76% for R0 resection and 75, 25, and 0% for R1 resection (p < 0.001). The 2, 5, and 8 year OS rates were 68, 43, and 26%, respectively. OS was better among patients with LC (p < 0.001). Twenty-four patients (58.5%) experienced a DF, and the 5 year OS rates for the patients with and without DF were 36 and 52%, respectively (p = 0.04). In a multivariate analysis, LF (p = 0,012) and recurrent retroperitoneal sarcoma (p = 0,014) were identified as significant predictors of worse OS. Thirteen patients (31%) developed clinically treatable complications related to IORT. CONCLUSIONS: Many patients achieve long-term OS and LC without significant morbidity after salvage surgery and IORT, especially in case of clear margins. BioMed Central 2018-11-20 /pmc/articles/PMC6245634/ /pubmed/30454036 http://dx.doi.org/10.1186/s13014-018-1168-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Coelho, Tharcisio Machado
Fogaroli, Ricardo César
Pellizzon, Antonio Cassio Assis
De Castro, Douglas Guedes
Gondim, Guilherme Rocha Melo
Silva, Maria Leticia Gobo
Chen, Michael Jenwei
Ramos, Henderson
Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
title Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
title_full Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
title_fullStr Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
title_full_unstemmed Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
title_short Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
title_sort intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245634/
https://www.ncbi.nlm.nih.gov/pubmed/30454036
http://dx.doi.org/10.1186/s13014-018-1168-x
work_keys_str_mv AT coelhotharcisiomachado intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT fogaroliricardocesar intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT pellizzonantoniocassioassis intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT decastrodouglasguedes intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT gondimguilhermerochamelo intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT silvamarialeticiagobo intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT chenmichaeljenwei intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis
AT ramoshenderson intraoperativeradiationtherapyforthetreatmentofrecurrentretroperitonealandpelvictumorsasingleinstitutionanalysis